Frequently asked questions
In 2022, the global Stretch Marks Treatment Market is expected to be worth USD 2.6 million.
The Stretch Marks Treatment Market is estimated to increase at a CAGR of 5.90% between 2023 and 2030, reaching USD 1314.0Million in 2030.
The Home Use Segment is estimated to lead the market throughout the forecast period.
The Adults sector is the market leader in Stretch Marks Treatment. Adults account for a bigger share of the market and have a higher need for stretch mark treatments than teenager
Direct Sales has the greatest CAGR in 2022
North America will account for 45.8% of total revenue in the Stretch Marks Treatment Market in 2022.
The top players include Weleda, Union Swiss (Pty) Ltd., Laboratoires Expanscience, HRA Pharma, Dermaclara, Candela Corporation, Clarins Group, Helix BioMedix Inc., Basq Skin Care, Alliance Pharma PLC, and E. T. Browne Drug Co. Inc. (Palmers), among others.
The increasing occurrence of stretch marks due to factors such as pregnancy, weight fluctuations, and growth spurts, as well as advancements in technology and research leading to more effective and novel treatment options, are the primary drivers of the market.
High treatment costs for stretch marks, limited insurance coverage for cosmetic operations, and potential side effects and hazards associated with specific treatment methods all impede market expansion.
Opportunities in the market include increasing consumer awareness and desire for effective solutions, technological advancements leading to more novel treatment alternatives, and the growing popularity of combination treatments for best outcomes.